Angle raises funds with placing

Angle, a specialist medtech company, has placed 4.53m new ordinary shares at 50p each, representing a discount of 17.4 per cent on the mid-price of 60.50p per share at close of business on Wednesday.

Angle, a specialist medtech company, has placed 4.53m new ordinary shares at 50p each, representing a discount of 17.4 per cent on the mid-price of 60.50p per share at close of business on Wednesday.

Net of costs, the placing raised £2.2m, which will be used to strengthen the company's financial position and support the launch of its Parsortix cancer diagnostic product for the research market.

The new shares represent around 10% of the enlarged issued share capital, with the total number following admission being 45.243m.

Founder and Chief Executive, Andrew Newland, said: "We are delighted that shareholders have recognised the progress made against milestones and have continued to support the company. The funds raised will enable us to continue the strong progress of our Parsortix system as we move into a new phase of product launch, validation and regulatory approval."

Angle is focused on achieving early sales in the research market and taking the necessary steps to allow Parsortix to be used in the much larger clinical market in the treatment of patients.

The group explained: "To support this work and to put the company in a stronger position from which to negotiate commercial deals in relation to its Parsortix platform, the board considered it appropriate to raise a somewhat larger sum of funding."

Half year losses narrowIn the six months ended October 31st, the group delivered a half year loss of £0.4m, compared to £1.8m the same period the previous year.

Revenue for the period fell from £0.7m to £0.47m, but this was offset by the charge in fair value, which came in at £0.29m, compared to -£1.35m in 2011.

The share price fell 6.61% to 56.50p by 13:45.

NR

Recommended

How to profit from India’s high-tech recovery
Share tips

How to profit from India’s high-tech recovery

Professional investor David Cornell of the India Capital Growth Fund, selects three of his favourite Indian stocks to buy now.
27 Sep 2021
Share tips of the week – 24 September
Share tips

Share tips of the week – 24 September

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
24 Sep 2021
Three strong Asian stocks trading at bargain prices
Share tips

Three strong Asian stocks trading at bargain prices

Professional investor Nitin Bajaj of the Fidelity Asian Values investment trust picks three stocks that dominate their industries, earn good returns o…
20 Sep 2021
Why it pays to face up to your investment mistakes
Investment strategy

Why it pays to face up to your investment mistakes

Buying stocks can be a complicated business. But selling stocks can be tricky, too – even if you sell for the right reasons. Max King explains how to …
17 Sep 2021

Most Popular

A nightmare 1970s scenario for investors is edging closer
Investment strategy

A nightmare 1970s scenario for investors is edging closer

Inflation need not be a worry unless it is driven by labour market shortages. Unfortunately, writes macroeconomist Philip Pilkington, that’s exactly w…
17 Sep 2021
Two shipping funds to buy for steady income
Investment trusts

Two shipping funds to buy for steady income

Returns from owning ships are volatile, but these two investment trusts are trying to make the sector less risky.
7 Sep 2021
What really causes inflation? Here’s what prices since 1970 tell us
Inflation

What really causes inflation? Here’s what prices since 1970 tell us

As UK inflation hits 3.2%, Dominic Frisby compares the cost of living 50 years ago with that of today, and explains how debt drives prices higher.
15 Sep 2021